MAXHEALTH.NS Stock — Price, Charts & Analysis

Max Healthcare Institute Limited (MAXHEALTH.NS) has a trailing P/E of 68.01x and a forward P/E of 42.69x. This places MAXHEALTH.NS in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

MAXHEALTH.NS trades with 68.01x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether MAXHEALTH.NS looks overvalued or undervalued.

MAXHEALTH.NS's P/E of 68.01x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

MAXHEALTH.NS's trailing EPS is ₹14.66 and forward EPS is ₹23.36. Reported earnings growth is 4.80%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit Max Healthcare Institute Limited generated for each share. MAXHEALTH.NS's trailing EPS is ₹14.66, and investors usually prefer EPS that is positive and growing over time.

Max Healthcare Institute Limited has a market cap of ₹970.36B, making MAXHEALTH.NS a large-cap stock based on the current market value shown on Worldtickers.

MAXHEALTH.NS's latest stock price on Worldtickers is ₹997.00. The latest move is -₹17.40 or -1.72%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

MAXHEALTH.NS's quote includes a latest price of ₹997.00. The market open is ₹1,016.00. Previous close is ₹1,014.40. The intraday range is ₹994.10 to ₹1,016.90.

MAXHEALTH.NS is down in the latest quote, with a move of -₹17.40 or -1.72%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

MAXHEALTH.NS generated ₹87.12B in trailing revenue. Revenue growth is 16.70%, which helps show whether demand is expanding or slowing.

MAXHEALTH.NS's revenue growth is 16.70%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, MAXHEALTH.NS shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is ₹14.57B.

Gross margin is 62.52%. Margins show how efficiently Max Healthcare Institute Limited turns revenue into profit.

Max Healthcare Institute Limited carries ₹34.78B and holds ₹6.66B in cash.

MAXHEALTH.NS holds ₹6.66B on its balance sheet.

MAXHEALTH.NS's book value per share is ₹110.43.

Yes, Max Healthcare Institute Limited pays a dividend of ₹2.00 per share annually. The dividend yield is 20.00%. The payout ratio is 13.41%.

MAXHEALTH.NS's dividend yield is 20.00%. Its payout ratio is 13.41%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for MAXHEALTH.NS. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through Max Healthcare Institute Limited's investor relations materials.

Institutions hold 61.38% of MAXHEALTH.NS shares. Insiders hold 28.20% of shares. Ownership mix helps investors understand how much of Max Healthcare Institute Limited is held by professional investors and company insiders.

MAXHEALTH.NS has 973.28M shares outstanding. Float shares are 699.04M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for MAXHEALTH.NS, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for MAXHEALTH.NS is ₹23.36. Earnings growth is 4.80%. Revenue growth is 16.70%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

MAXHEALTH.NS's trailing EPS is ₹14.66. Forward EPS is ₹23.36. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

MAXHEALTH.NS is in the Healthcare sector. Its earnings multiple is 68.01x. Its latest displayed growth metric is 16.70%. Compare these figures with sector peers before deciding whether Max Healthcare Institute Limited is stronger or weaker than average.

MAXHEALTH.NS trades at ₹997.00. The stock trades at 68.01x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Max Healthcare Institute Limited's fundamentals.

MAXHEALTH.NS risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.13, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

MAXHEALTH.NS should be compared with companies in Medical Care Facilities. Its earnings multiple is 68.01x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Max Healthcare Institute Limited (MAXHEALTH.NS) operates in Healthcare, specifically Medical Care Facilities. Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, bone marrow transplant, bariatric/weight loss surgery, gynecology, minimal access/laparoscopic surgery, eye care/ophthalmology, robotic surgery, paediatrics, nephrology, liver and biliary sciences, gastroenterology and GI surgery, internal medicine,

MAXHEALTH.NS trades on NSE. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

MAXHEALTH.NS stock is priced in INR on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Max Healthcare Institute Limited's official website listed on Worldtickers is www.maxhealthcare.in. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Max Healthcare Institute Limited is headquartered in Gurugram, India. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

MAXHEALTH.NS is in the Healthcare sector and the Medical Care Facilities industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

MAXHEALTH.NS has traded between ₹903.00 and ₹1,256.00 over the past 52 weeks. At ₹997.00, it is 20.62% below the high and 10.41% above the low. The 52-week range helps gauge long-term price momentum.

MAXHEALTH.NS is below both its 50-day and 200-day moving averages, which is a common downtrend signal. Its 50-day moving average is ₹1,080.96 and its 200-day moving average is ₹1,047.31.

MAXHEALTH.NS's RSI is 31.22. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

MAXHEALTH.NS's latest RSI reading is 31.22, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for MAXHEALTH.NS is near ₹981.10. Key resistance is near ₹1,135.90. Breaks above resistance or below support can change the short-term technical setup.

MAXHEALTH.NS's nearest reported support level is ₹981.10. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

MAXHEALTH.NS's nearest reported resistance level is ₹1,135.90. A breakout above resistance can improve momentum, especially when volume confirms the move.

MAXHEALTH.NS trades about 2.57M shares daily on average. The latest displayed volume is 1.32M shares. Volume helps show liquidity and whether trading interest is unusually high or low.

MAXHEALTH.NS's MACD is -8.85, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

MAXHEALTH.NS is below both its 50-day and 200-day moving averages, which is a common downtrend signal. RSI is 31.22 (neutral). MACD is bearish. Nearest support is around ₹981.10. Resistance is around ₹1,135.90. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is ₹1,063.60 (-6.26% from price). MA50 is ₹1,080.96 (-7.77% from price). MA200 is ₹1,047.31 (-4.80% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. MAXHEALTH.NS's MA20 is ₹1,063.60. MA50 is ₹1,080.96. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

MAXHEALTH.NS's pivot is near ₹1,004.50. Support is near ₹981.10. Resistance is near ₹1,135.90. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for MAXHEALTH.NS is near ₹962.49. The next upper resistance zone is near ₹1,024.27. These levels help define risk and possible follow-through zones after a breakout or breakdown.

MAXHEALTH.NS's Bollinger range is roughly ₹981.25 to ₹1,145.95. Band width is near 15.49%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

MAXHEALTH.NS's ATR-based typical daily range is about 2.89%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 1.32M shares. Average volume is about 2.57M shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

MAXHEALTH.NS's all-time high shown on Worldtickers is ₹1,314.30. Its all-time low is ₹97.15. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

MAXHEALTH.NS has a beta of 0.13, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.